Q
QuantAbundance

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

31,229 signal articles · 0 in last 24h · 160,153 total before filter · latest 2d ago
0last 24h
574last 7d
84● bullish (7d)
64● bearish (7d)
214publishers
AllMacro106Earnings160M&A57Regulatory12Product10Analyst16
✕ clear all filtersticker: NVDASentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Forget P&G: This Defensive Cash-Flow Powerhouse Just Beat Earnings and Is a Best Buy Today
24/7 Wall St.109d agobullish
Forget P&G: This Defensive Cash-Flow Powerhouse Just Beat Earnings and Is a Best Buy Today

Procter & Gamble (NYSE:PG) is the household name every retirement portfolio reaches for when markets get choppy, and its $350.4 billion market cap makes it the default consumer defensive trade on every desk. The internals tell a different story. The Crowded Trade Is Quietly Cracking P&G beat its most recent quarter, but the internals are ... Forget P&G: This Defensive Cash-Flow Powerhouse Just Beat Earnings and Is a Best Buy Today

Up 23% From Its 52-Week Low: 1 Critical Metric That Explains Why I’m Standing Pat on Coca-Cola Stock
24/7 Wall St.109d agoneutral
Up 23% From Its 52-Week Low: 1 Critical Metric That Explains Why I’m Standing Pat on Coca-Cola Stock

At $80.91, Coca-Cola (NYSE:KO) sits in a holding pattern. Shares have rallied roughly 23% off the 52-week low and now trade where high risk-free Treasury yields are squeezing defensive staple multiples. Coca-Cola is the largest nonalcoholic beverage system in the world, anchored by sparkling soft drinks and increasingly carried by double-digit volume growth in Coca-Cola ... Up 23% From Its 52-Week Low: 1 Critical Metric That Explains Why I’m Standing Pat on Coca-Cola Stock

This $15 Billion Operational Beat Just Rewrote the Entire Bear Thesis for AbbVie
24/7 Wall St.109d agobullish
This $15 Billion Operational Beat Just Rewrote the Entire Bear Thesis for AbbVie

For income investors weighing biopharma exposure, the dividend question on AbbVie (NYSE:ABBV) just got a lot easier to answer. The company posted $15.002 billion in Q1 2026 revenue, beating consensus by $284 million, and management raised full-year adjusted EPS guidance to $14.08 to $14.28. With the stock yielding nearly 3%, the question is whether the ... This $15 Billion Operational Beat Just Rewrote the Entire Bear Thesis for AbbVie

What investors should know before hopping on SpaceX options trades
Yahoo Finance Video109d agoneutralVIDEO
What investors should know before hopping on SpaceX options trades

While SpaceX (SPCX) holds onto stock gains in Tuesday's session, the options market has been abuzz today as more traders chase options contracts on the space company. YieldMax ETFs chief strategist Mike Khouw comes on Market Domination to speak more about what retail investors should beware of when hopping into options trades on a company fresh off of its IPO.

XRP Holders With 1 Million Coins Now Own 74% of the Supply
24/7 Wall St.109d agoneutral
XRP Holders With 1 Million Coins Now Own 74% of the Supply

For the past six months, XRP (CRYPTO:XRP) slid lower as the Iran war battered the whole market, and plenty of holders gave up and sold. However, the biggest holders did the exact opposite. Wallets holding a million coins or more now own almost three-quarters of all the XRP in existence, and they did that by ... XRP Holders With 1 Million Coins Now Own 74% of the Supply

Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?
24/7 Wall St.109d agobullish
Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?

Moderna (NASDAQ:MRNA) stock is jumping again. Shares are up 9% today, trading near $57 in the Tuesday afternoon session. That extends a remarkable 2026 run for the mRNA pioneer. The move pushes Moderna stock to +94% year to date (YTD), easily the best performance in the major vaccine cohort. By comparison, Pfizer (NYSE:PFE) stock is ... Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?

QQQI’s 13.8 Percent Monthly Yield Comes With a Hidden Cost Most Income Investors Miss
24/7 Wall St.109d agobearish
QQQI’s 13.8 Percent Monthly Yield Comes With a Hidden Cost Most Income Investors Miss

NEOS Nasdaq-100 High Income ETF (NASDAQ:QQQI) offers a roughly 13.8% distribution yield, paid monthly, on a portfolio holding NVIDIA, Apple, and Microsoft. For income investors tired of 4% Treasuries and 2% dividend funds, QQQI looks like a cheat code. The question is whether that headline yield is durable income or partly a refund of your ... QQQI’s 13.8 Percent Monthly Yield Comes With a Hidden Cost Most Income Investors Miss

Micron Technology Inc (MU) Gets Nvidia Nod For AI Memory Supply
Insider Monkey109d agoneutral
Micron Technology Inc (MU) Gets Nvidia Nod For AI Memory Supply

Micron Technology Inc (NASDAQ:MU) is one of billionaire Ken Fisher’s top high growth stock picks. Micron has emerged as one of investors’ favorite semiconductor stocks amid the AI boom. The stock has surged more than 196% year-to-date and exploded 720% over the past year. Micron Technology Inc (NASDAQ:MU) has been approved to supply HBM4 memory […]

Nvidia Corp (NVDA) Lands AI Infrastructure Deals in South Korea
Insider Monkey109d agoneutral
Nvidia Corp (NVDA) Lands AI Infrastructure Deals in South Korea

Nvidia Corp (NASDAQ:NVDA) is one of billionaire Ken Fisher’s top high growth stock picks. Nvidia shares have gained more than 10% year-to-date and soared more than 45% over the past year. Analysts expect the stock to keep rising, forecasting nearly 50% upside to the current price. On June 7, Nvidia Corp (NASDAQ:NVDA) announced a large […]

DGP vs. UGL: Which 2x Gold Play Costs You More Than the Leverage?
24/7 Wall St.109d agoneutral
DGP vs. UGL: Which 2x Gold Play Costs You More Than the Leverage?

Investors looking for 2x daily exposure to gold typically land on two tickers: DB Gold Double Long ETN (NYSEARCA:DGP) and ProShares Ultra Gold (NYSEARCA:UGL). On a one-day basis they move almost in lockstep, both up roughly 7.4% and 7.1% respectively in today’s session. The real distinction sits beneath the ticker: one is a senior unsecured ... DGP vs. UGL: Which 2x Gold Play Costs You More Than the Leverage?